Skip to main content

Table 2 Comparison between the VTE group and the non-VTE group.(M [Q1,Q3]).

From: Early identification of lung cancer patients with venous thromboembolism: development and validation of a risk prediction model

Group

n

FDP(mg/L)

D-dimer(µg/mL)

TM(TU/ml)

TAT(ng/ml)

PIC(ug/ml)

tPAI-C(ng/ml)

VTE

27

11.01(4.40-28.07)

3.52(1.27–9.49)

12.60(10.70–15.10)

4.50(2.70–9.50)

1.64(1.03–1.95)

8.90(7.60–14.70)

Non-VTE

131

2.59(1.77–4.28)

0.58(0.37–1.27)

9.30(7.70–10.70)

2.20(1.30–3.30)

0.95(0.70–1.39)

7.10(5.10–9.10)

Z value

 

-6.015

-5.871

-5.142

-4.870

-3.989

-3.005

P-value

 

< 0.001*

< 0.001*

< 0.001*

< 0.001*

< 0.001*

= 0.003*

  1. Abbreviation:* p-Value < 0.05
Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us